Provided by Tiger Trade Technology Pte. Ltd.

Biodesix, Inc.

14.88
-1.4250-8.74%
Post-market: 14.880.00000.00%19:46 EDT
Volume:91.92K
Turnover:1.43M
Market Cap:146.64M
PE:-3.19
High:17.00
Open:16.80
Low:14.63
Close:16.30
52wk High:20.21
52wk Low:3.44
Shares:9.86M
Float Shares:3.02M
Volume Ratio:0.92
T/O Rate:3.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6700
EPS(LYR):-6.6216
ROE:-383.09%
ROA:-18.79%
PB:-59.49
PE(LYR):-2.25

Loading ...

Jack W. Schuler, 10% Owner, Acquires Common Shares of Biodesix Inc

Reuters
·
Jan 26

Biodesix Inc. Chief Accounting Officer Chris Vazquez Reports Disposal of Common Shares

Reuters
·
Jan 21

Biodesix Chief Development Officer Gary Pestano Reports Disposal of Common Shares

Reuters
·
Jan 21

Biodesix CFO Robin Harper Cowie Reports Sale of Common Shares

Reuters
·
Jan 21

Biodesix (BDSX) Receives a Buy from Lake Street

TIPRANKS
·
Jan 13

Biodesix trading halted, volatility trading pause

TIPRANKS
·
Jan 13

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:45 AM

Reuters
·
Jan 13

Top Premarket Gainers

MT Newswires Live
·
Jan 12

Biodesix prelim Q4 revenue beats expectations, helped by growth in Lung Diagnostics

Reuters
·
Jan 12

Biodesix Q4 Revenue Rises 41% to USD 28.8 Million

Reuters
·
Jan 12

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)

THOMSON REUTERS
·
Jan 12

Biodesix Inc - Affirms Guidance of Adjusted Ebitda Positivity in Q4 2025

THOMSON REUTERS
·
Jan 12

Biodesix Inc - Full-Year Revenue Estimated at $88.5 Mln

THOMSON REUTERS
·
Jan 12

Biodesix Q4 Revenue USD 28.8 Million VS. Ibes Estimate USD 24.3 Million

THOMSON REUTERS
·
Jan 12

Biodesix to Present New Data at Two Major Upcoming Scientific Meetings

GlobeNewswire
·
Dec 03, 2025

Biodesix Q3 Revenue USD 21.8 Million Vs. IBES Estimate USD 20.8 Million

Reuters
·
Nov 20, 2025

Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth

TIPRANKS
·
Nov 05, 2025

Biodesix (BDSX) Gets a Buy from Lake Street

TIPRANKS
·
Nov 04, 2025

Cautious Optimism: Biodesix’s Strong Performance Amid Cash Runway and Profitability Concerns

TIPRANKS
·
Nov 04, 2025

Biodesix Reports Strong Q3 2025 Revenue Growth

TIPRANKS
·
Nov 04, 2025